Banghula, Mayeth L.
HRN: 29-14-12 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/18/2026
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
07/18/2026
07/24/2026
IV
2.25
Od
Surgical Site Infection
Checking Final Appropriateness
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes